T5	Subject 0 8	Patients
T6	Treatment 22 36	L-asparaginase
T8	Effect 54 103	hemorrhagic and thrombotic cerebrovascular events
T9	Drug 22 36	L-asparaginase
T10	Speculation_cue 37 40	may
T7	Adverse_event 41 48	present
E1	Adverse_event:T7 
A1	Speculated E1
